Contributions from multiple cathepsins within endosomal antigen processing compartments are necessary to process antigenic proteins into antigenic peptides. Cysteine and aspartyl cathepsins have been known to digest antigenic proteins. A role for the serine protease, Cathepsin G (CatG), in this process has been described only recently, although CatG has long been known to be a granule-associated proteolytic enzyme of neutrophils. In line with a role for this enzyme in antigen presentation, CatG is found in endocytic compartments of a variety of antigen presenting cells. CatG is found in primary human monocytes, B cells, myeloid dendritic cells 1 (mDC1), mDC2, plasmacytoid DC (pDC), and murine microglia, but is not expressed in B cell lines or monocytederived DC. Purified CatG can be internalized into endocytic compartments in CatG nonexpressing cells, widening the range of cells where this enzyme may play a role in antigen processing. Functional assays have implicated CatG as a critical enzyme in processing of several antigens and autoantigens. In this review, historical and recent data on CatG expression, distribution, function and involvement in disease will be summarized and discussed, with a focus on its role in antigen presentation and immune-related events.
The protein product of the CTSG gene is a 255 amino acid polypeptide, representing preproCatG. After cleavage of the signal peptide, two amino acids remain at the N-terminal side of proCatG, which can be released by CatC. The observation that CatG-activity is not found in a CatC knockout mouse demonstrates that CatC is crucial for activation of CatG (Adkison et al., 2002) . The C-terminal extension of 11 amino acids is digested by an unknown protease (McGuire et al., 1993; Salvesen et al., 1987) . There are several isoforms of CatG: C1, C2, and C3 all contain one N-glycosylation site at asparagine-64 (N64) where a combination of fucose, mannose, galactose, N-acetylglucosamine, and N-acetylneuraminic acid, are added; C4 is not glycosylated (Watorek et al., 1993) . Functional differences between these isoforms have not been defined.
CatG has chymotrypsin-and trypsin-like activity and has activity across a broad pH spectrum (optimal between pH 7-8). The catalytic triad of aspartate, histidine and serine residues forms the CatG active site that hydrolyzes a peptide bond precisely after aromatic and strongly positively charged residues (F, K, R, or L) in the P1 position (Wysocka et al., 2007) . At the P1′ position every amino acid is apparently accepted, although serine and an acidic residue is preferred at P2′ (Figure 1 ) (Rehault et al., 1999) .
Cathepsin G in neutrophils: a brief overview
CatG is best known as one of three serine proteases, neutrophil elastase (NE), CatG, and proteinase 3 (PR3), expressed in the azurophilic granules of neutrophils (Baggiolini et al., 1978; Baggiolini et al., 1979) . These proteases are thought to be critically important in maintaining the delicate balance between tissue protection and destruction during an inflammatory response. They are involved in a broad range of functions in neutrophlis, including clearance of internalized pathogens, proteolytic modification of chemokines and cytokines, activation as well as shedding of cell surface receptors and apoptosis (reviewed in (Meyer-Hoffert, 2009; Nathan, 2006; Pham, 2006; Pham, 2008) .
The anti-microbial activities of CatG and PR3 include both proteolysis-dependent and independent mechanisms, in contrast to NE, whose anti-bacterial activity is limited to proteolytic cleavage of membrane proteins of Gram-negative bacteria (Cole et al., 2001; Korkmaz et al., 2008; Ohlsson et al., 1977) . The region of CatG including amino acids 117-136 is arginine-rich, and these cationic residues interfere with the negatively-charged bacterial surface in a proteolytic independent way (Odeberg and Olsson, 1975; Shafer et al., 1996; Shafer and Onunka, 1989; Shafer et al., 1986) . Consistent with its anti-microbial activity, CatG deficiency in gene-targeted mice increases susceptibility to Staphylococcus aureus and fungal infections (Reeves et al., 2002; Tkalcevic et al., 2000) .
CatG also has important effects that regulate chemotaxis. It cleaves the N-terminal residues of chemokine (C-X-C motif) ligand 5 (CXCL5) and chemokine (C-C motif) ligand 15 (CCL15) to generate more potent chemotactic factors for neutrophils and monocytes, respectively (Nufer et al., 1999; Richter et al., 2005) . CatG (and NE) converts prochemerin to chemerin, a novel chemoattractant for APC (Wittamer et al., 2005) . The secretion of the chemotactic factor CXCL2 by neutrophils also depends on the action of CatG (Raptis et al., 2005) . In opposing effects, CatG degrades chemokines CCL5, CCL3, CXCL12 and the chemokine receptor, CXCR4 (reviewed in (Pham, 2008) .
CatG and the other 2 neutrophil serine proteases are stored in azurophil granules in active form. They are secreted in limited amount following certain stimuli (Bank and Ansorge, 2001; Meier et al., 1985) . It is generally believed that the secreted proteases remain bound and active on the cell surface membrane (Owen and Campbell, 1999a; Owen and Campbell, 1999b) . There, CatG can increase integrin clustering, which regulates neutrophil effector functions (Raptis et al., 2005) . Secreted CatG and γ-secretase also cleave CD43 from the neutrophil cell surface, which may be important for cell migration (Mambole et al., 2008) . In the circulation, most soluble serine proteases are probably bound in a 1:1 stoichiometry with serine protease inhibitors (serpins) (Medema et al., 2001; Remold-O'Donnell et al., 1992) . However, in the extravascular environment, they may escape inhibition and bind to other cells. For example, CatG binds to and activates protease activated receptor 4 (PAR4) on platelets, influencing neutrophil-platelet interactions at sites of inflammation (Sambrano et al., 2000) . Overall, the proteolytic activities of neutrophil associated CatG are many and have significant immune-related effects, including host defense. It will be of interest in future studies to determine which of these activities are shared by APCs where CatG is found in endocytic compartments that are akin to azurophilic granules.
Antigen presenting cells
B cells, macrophages, microglia, and dendritic cells (DC) are professional antigen presenting cells (APC). DC, the APC par excellence, often serve as a link between the innate and adaptive immunity and play a key role in maintaining tolerance (Banchereau and Steinman, 1998) . Based on the location, activation status and function, DC are divided into three different categories: conventional DC, plasmacytoid DC (pDC) and inflammatory DC, respectively (for review (Shortman and Naik, 2007; Villadangos and Schnorrer, 2007) ).
Antigen processing and presentation by professional APC
Major histocompatibility complex (MHC) class II molecules together with the MHC IIassociated invariant chain (Ii), p31 (~31 kDa, li ) and the splice variant p41 (~41 kDa, li 1-280 ), are expressed and assembled in the ER, forming a nonameric (αβIi) 3 -complex. Trafficking through endocytic compartments, li of the (αβIi) 3 -complex is C-terminal sequentially degraded into the N-terminal containing intermediates p22 (~22 kDa), p18 (~18 kDa), p10 (~10 kDa, li 1-104 ), and finally to class II-associated Ii peptide (CLIP, ~3 kDa, li ) fragment. It is now clear that CatS plays a central role in converting p10 into CLIP in DC (Riese et al., 1996; Villadangos et al., 1997) , however, it remains uncertain, which proteases are involved in the initial step of li processing and the respective cleavage site. The remaining CLIP-peptide occupies the MHC class II binding groove, preventing premature loading of antigenic peptides (Busch et al., 2005; Chapman, 2006; Watts, 2004) . The MHC-related molecule HLA-DM noncovalently catalyzes the exchange of CLIP from the binding groove of MHC class II molecules for more stable peptides to form peptide/MHC II-complexes (reviewed in (Busch et al., 2005) . These complexes are transported to the cell surface, for presentation to the T cell receptor (TCR) of CD4 + T cells (Maynard et al., 2005) .
Less molecular detail is known about the processes involved in generating the ligands that replace CLIP. APC, in particular DC, are capable of taking up foreign antigens, as well as autoantigens, into endocytic compartments (endosomes and lysosomes) to be digested into appropriate fragments for loading to MHC class II molecules and subsequent presentation to CD4 + T cells. The endocytic compartments contain antigen processing machinery, including reducing agents (such as gamma-interferon-inducible lysosomal thiol reductase, GILT) and proteases, specifically different classes of cathepsins. The cathepsins degrade both MHC IIassociated invariant chain (Ii) to class II-associated Ii peptide (CLIP) and endosomallydelivered proteins into peptides for binding to MHC class II molecules (Busch et al., 2005; Chapman, 2006; Villadangos et al., 2005; Watts, 2004) .
Cathepsins of the cysteine and aspartyl protease classes
According to the amino acid within their active site, cathepsins are divided into three classes: cysteine, aspartyl, and serine. At the active site of cysteine cathepsins, histidine and asparagine residues polarize the cysteine residue, which carries out nucleophilic attack on the carbonyl carbon of an amide bond . The cysteine cathepsins of the CA clan include CatB, C, F, H, S, L, V, and X. Together with the CD clan-associated asparagine endoprotease (AEP), the cysteine proteases are involved in antigen and li processing and have been extensively reviewed elsewhere (Bromme et al., 1999; Chapman, 2006; Colbert et al., 2009; Manoury et al., 2002b; Rudensky and Beers, 2006; Shi et al., 2000; Turk et al., 2000; Villadangos and Ploegh, 2000; Watts et al., 2005; Zavasnik-Bergant and Turk, 2006) .
CatD and CatE, members of the aspartyl protease family, also participate in antigen processing. CatD is expressed in all cells (except erythrocytes), whereas CatE expression is restricted to APC (Bennett et al., 1992; Burster et al., 2008; Chain et al., 2005; Hewitt et al., 1997; Moss et al., 2005; Zaidi et al., 2007) . In APC, CatE is localized to endosomes, while CatD is primarily located in lysosomes (for review see ). Less is known about the serine protease CatG in antigen processing. This enzyme and its function in APC is the main focus of this review.
Distribution and function of CatG within APC 1. CatG expression by the professionals
The ability to process proteins into antigenic peptides requires the concerted action of multiple cathepsins in all APC. However, the specific expression pattern of cathepsins varies in different APC. CatG is found in primary human B cells, both subsets of DC (mDC1 and mDC2), cortical thymic epithelial cells (cTEC), and at maximum levels in pDC (summarized in Table 1 ). In the mouse, CatG is expressed in microglia and splenic DC. However, CatG is not found in B lymphoblastoid cell lines (BLC), monocyte-derived DC, and fibroblast cell lines. This indicates an important functional difference between primary cells and certain model antigen presenting cells and highlighting the value of assessing antigen processing in primary cells (Burster et al., 2004; Burster et al., 2005; ).
Primary human mDC1, pDC, and CD19 + B cells express CatG endogenously ). CatG is not endogenously synthesized in primary CD22 + B cells as CatG transcripts are not detectable in these cells (Burster et al., 2004) . However, cells without endogenous expression of CatG can take up the secreted form of this enzyme. Purified CatG binds to a thrombin-like receptor at the cell surface of lymphocytes, including CD4 + , CD8 + , NK, and B cells (Yamazaki and Aoki, 1997) . CatG binding to its receptor is specific and reversible. Interestingly, the serine protease inhibitor phenylmethane sulfonyl fluoride (PMSF) partly interferes with the interaction of CatG with the receptor, implicating the active conformation of CatG in the mechanism of receptor binding (Yamazaki and Aoki, 1997) . Data from purified B cells indicate that the surface CatG receptor is not constitutively saturated in circulating B cells and can bind more CatG from the serum (Delgado et al., 2001) . CatG becomes active when bound to the receptor of lymphocytes (Owen and Campbell, 1998; Owen et al., 1995b) . Indeed, when added to cultures of CatG nonexpressing B lymphoblastoid cells, purified CatG is internalized into endocytic compartments, suggesting that B cells may upgrade their protease repertoire and antigen processing capacity from exogenous sources (summarized in Figure 2 and (Burster et al., 2004) . The paradigm that additional proteases from exogenous origin can contribute to the antigen processing compartment is not without precedent, as was previously shown for AEP .
Antigen processing by CatG in different APC
Studies first implicating CatG as an important antigen processing enzyme focused on the processing of myelin basic protein (MBP) as a model autoantigen. MBP is one of several key autoantigens associated with the pathogenesis of multiple sclerosis (also myelin oligodendrocyte glycoprotein (MOG) and proteolipid protein (PLP)). The cationic arginine residues of MBP interact with the negatively-charged phosphate groups of lipid bilayers, ensuring adhesiveness between the lipid layers and forming the myelin sheath (for review, see . In initial studies of MBP processing, CatG activity was not assessed, because its absence from BLC suggested it did not contribute to the antigen processing machinery. CatS and AEP were found to control MBP processing in BLC (Beck et al., 2001; Manoury et al., 2002a) , However, the processing of MBP with lysosomal proteases derived from primary human B cells differed from that observed with BLC (Burster et al., 2004) . Indeed, MBP digestion by primary B cell-derived lysosomal proteases was not impaired using an MBP mutant lacking the AEP cleavage site. Biochemical characterization of primary B cells showed that neither AEP protein nor AEP activity was present in these cells (Burster et al., 2004) .
To examine CatG as a potential protease involved in MBP processing, we incubated MBP with purified CatG and analyzed the resulting fragments using HPLC, mass spectrometry, and micro-sequencing. We found that CatG cleaves this protein, and its processing site is in the middle of the MBP immunodominant epitope (MBP85-99) between phenylalanine 90 (F90) and lysine (K91). Consistent with this finding, when B cells and MBP 84-98 -reactive T cells were incubated with in vitro CatG-digested MBP, T cell proliferation was reduced to background levels (Burster et al., 2004) . When CatG-preloaded fibroblasts are pulsed with MBP, diminished MBP 84-98 -specific T cell proliferation also results ). As fibroblasts do not express CatG, these data indicate that endocytosed CatG is also functional in antigen processing. CatG generates a second T cell epitope, MBP115-123, by hydrolyzing the peptide bond between phenylalanine 114 and serine 115. Thus, CatG can both destroy and generate specific T cell epitopes (Burster et al., 2004 ) (for AEP also see . We obtained the same CatG fragmentation pattern using lysosomal proteases from primary human B cells, suggesting a dominant role of CatG in processing of MBP by these cells (Burster et al., 2004) .
In another study, we observed distinct fragmentation of MBP and MOG by human mDC1 lysosomal proteases compared to lysosomal proteases of monocyte-derived DC. CatG controlled the turnover of MBP and MOG by mDC1 lysosomal proteases. mDC1 lack significant amounts of active CatL, CatC, and AEP. In contrast, with lysosomal proteases from monocyte-derived DC, MBP, and MOG processing was dominated by CatS, CatD, and AEP . These differences in the endocytic proteolytic machinery between in vitro generated monocyte-derived DC and primary mDC demonstrate a potential limitation of using monocyte-derived DC to predict in vivo processing of antigens (Delamarre et al., 2005; Dudziak et al., 2007) . Our results also indicate that AEP is dispensable for processing of MBP in primary human B cells and mDC1. AEP is expressed in pDC and mDC2 , in line with the possibility that pDC represent pre-DC, which are thought to have higher protease activity, facilitating antigen processing in these cells.
Data showing reduced presentation of hemagglutinin (HA) and tetanus toxin C-fragment (TTC) after uptake of the specific CatG-inhibitor were also obtained (Reich et al., 2009) . Definitive evidence of the biological importance of these functional findings with CatG will require investigation in animal models, such as CatG knockout mice (Tkalcevic et al., 2000) .
Regulation of CatG in APC
Microglia cells represent a functionally important APC in the CNS (Gonzalez-Scarano and Baltuch, 1999) . When murine microglia are treated with IFN-γ to mimic a proinflammatory cytokine milieu, CatG is downregulated, whereas the activities of CatS, CatB, CatL, CatD, and AEP are unchanged. Furthermore, when lysosomal cathepsins from IFN-γ-treated murine microglia are incubated with MBP, the stability of MBP is increased compared to incubation with cathepsins from control cells. The differences in MBP processing are eliminated when a serine protease inhibitor, PMSF, is added, suggesting that IFN-γ mediated reductions in active CatG alter the processing of MBP . Regulation of CatG activity was also observed in human monocyte-derived DC during culture in IL-4 and GM-CSF; monocyte-derived DC at day five of culture contain CatGactivity, but CatG decreases after day seven (Ishri et al., 2004) . Indeed, using the activitybased probe peptidyl (α-aminoalkyl) phosphonate diphenyl ester (DAP022c (Oleksyszyn and Powers, 1991) ) to visualize active CatG, no CatG activity is detected in monocytederived DC, cultured for six days. CatG activity is not upregulated in monocyte-derived DC (day 6) after stimulation with LPS, IFN-γ, or TNF-α for 24 h . We also found reduced CatG-activity, when primary mDC1 were activated with LPS and analyzed with the DAP022c activity-based probe for serine proteases (Burster unpublished data) . Other cell types increase CatG after cytokine treatment. For instance, TNF-α stimulates higher levels of CatG in HeLa cells and increases cell surface levels and secretion of CatG in PMN (Eliassen et al., 2000; McGettrick et al., 2001; Owen et al., 1995a) . Therefore, regulation of CatG depends not only on the activation stimuli, but also on the type of APC. Cytokine regulation of CatG activity in antigen presenting cells and its relationship to antigen processing/presentation warrants further investigation.
Protein degradation by CatG
In addition to processing MBP, MOG, TTC, HA, and type 1 diabetes mellitus (T1D)-associated autoantigen Burster et al., 2005; Reich et al., 2009 ), CatG at the surface of mononuclear cells has been shown to digest cell surface proteins. For example, CatG on the cell surface of blood lymphocytes cleaves and inactivates surface chemokine stromal cell-derived factor 1 (SDF-1), which acts as a maturation factor for B cell-precursors (Delgado et al., 2001 ). In addition, soluble forms of CD2, CD4, CD87, IgG, IgM, elastine, and VCAM-1 have been shown to be generated by CatG-mediated cleavage at the cell surface (Baici et al., 1982a; Baici et al., 1982b; Boudier et al., 1991) . Interestingly, CatG is thought to contribute to the inflammatory response (Miyata et al., 2007) , but also cleaves CD14, a receptor for LPS, and reduces its cell surface expression (Le-Barillec et al., 2000) . CatG also degrades CD2 at the T cell surface, leading to a temporary inhibition of chronic inflammation in patients with cystic fibrosis (Doring et al., 1995) . Further, CatG degrades TNF-α into two fragments (Scuderi et al., 1991) and activates TGF-b signal transduction (Wilson et al., 2009) . By regulating levels of CD14, CD2, and TNF-α, CatG may have anti-inflammatory properties.
Diseases associated with CatG
To date, there are no diseases that have been shown to derive directly from mutation of CatG. However, mutation of CatC, which digests two amino acids from proCatG to generate mature CatG, is associated with Papillon-Lefèvre syndrome (PLS) (Castori et al., 2009; Hart et al., 1999; Ochiai et al., 2009; Pham et al., 2004; Toomes et al., 1999; Yang et al., 2007) . PLS is an extremely rare genetic disorder characterized by severe peridonontitis and palmoplantar hyperkeratosis (PPK), which is marked thickening of the epidermis on the palms and soles (Gorlin et al., 1964; Hart and Shapira, 1994) . The role of CatC in the pathogenesis of PLS and PPK is not well understood.
A discreet role in disease pathogenesis for CatG as an antigen processing enzyme has not been described. However, substantial evidence implicates CatG (along with NE and PR-3) from neutrophil granules in a number of inflammatory processes. For example, increased levels of CatG, correlating with neutrophil count, are found in synovial fluid and tissue in rheumatoid arthritis (RA) and contribute to chemotactic activity for monocytes (Miyata et al., 2007) . Notably, mice deficient in CatC and CatG are resistant to experimental arthritis (Adkison et al., 2002; Hu and Pham, 2005) . Neutrophil serine proteases also contribute to various lung disorders (Kamp et al., 1993; Nygaard et al., 1993; Okrent et al., 1990; Peterson et al., 1995; Van Wetering et al., 1997) . Co-administration of CatG and NE cause emphysema and bronchial secretory cell metaplasia in a hamster model (Lucey et al., 1985) , and inhaled CatG induces airway hyperresponsiveness, a signature feature of asthma, in a rat model, (Coyle et al., 1994) . In investigations related to cardiovascular disease, CatG inactivates (Anderssen et al., 1993; Turkington, 1991) or activates coagulation factors (Allen and Tracy, 1995; Gale and Rozenshteyn, 2008) , and induces platelet activation and aggregation (LaRosa et al., 1994; Molino et al., 1992; Selak and Smith, 1990) . CatG also might induce cardiac injury (Sabri et al., 2003) . CatG activity likely also influences the tumor environment. For example, at the mammary tumor-bone interface, CatG enhances osteoclast activation and subsequent bone resorption (Wilson et al., 2008) .
Conclusion
Improved understanding of antigen processing in the MHC class II antigen presentation pathway is of fundamental interest and is needed for CD4 + T cell epitope prediction. One contribution to this effort will be investigating the degradation of various proteins using specific cathepsin inhibitors to determine the roles of the numerous proteases found in the endocytic compartments. We have reviewed findings on the serine protease CatG within antigen presenting cells. CatG, like other cathepsins, is differentially expressed within various APC types. CatG is found and functional in primary human monocytes, B cells, mDC1, mDC2, pDC, and murine microglia and purified CatG can be internalized into endocytic compartments in CatG non-expressing cells to expand their protease repertoire. Elucidation of the contributions of specific proteases in specific APC types will be necessary to inhibit epitope generation in particular APCs as a strategy for therapeutic immunomodulation. It will be important to consider CatG in the design of these future studies in intra-as well as extracellular antigen processing, in microbial defense and inflammatory settings. - (9) CD22 B cell CD22 is an inhibitory co-receptor of B cell receptor (BCR)-mediated signaling, found on mature peripheral blood B cells and lost during differentiation to plasma cells. ~5 % of PBMC.
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